Dawn Zier Net Worth

The estimated Net Worth of Dawn M. Zier is at least $13.8 Millón dollars as of 15 November 2023. Ms. Zier owns over 5,000 units of Prestige Consumer Healthcare Inc stock worth over $4,889,856 and over the last 9 years she sold PBH stock worth over $8,910,965. In addition, she makes $36,261 as Independent Director at Prestige Consumer Healthcare Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms. Zier PBH stock SEC Form 4 insiders trading

Dawn has made over 22 trades of the Prestige Consumer Healthcare Inc stock since 2016, according to the Form 4 filled with the SEC. Most recently she bought 5,000 units of PBH stock worth $56,250 on 15 November 2023.

The largest trade she's ever made was exercising 30,825 units of Prestige Consumer Healthcare Inc stock on 12 February 2018 worth over $658,114. On average, Dawn trades about 7,943 units every 38 days since 2015. As of 15 November 2023 she still owns at least 68,755 units of Prestige Consumer Healthcare Inc stock.

You can see the complete history of Ms. Zier stock trades at the bottom of the page.

Dawn Zier biography

Dawn M. Zier serves as Independent Director of the Company. Ms. Zier served as President and CEO of Nutrisystem, a leading provider of weight loss solutions and services. Upon acquisition of Nutrisystem, Ms. Zier joined Tivity Health, a leading provider of nutrition, fitness and social engagement solutions. Prior to that she held a variety of executive positions at Reader’s Digest Association, a global media and data marketing company. Ms. Zier also serves on the boards of The Hain Celestial Group, Inc. and Spirit Airlines and previously served on the board of Velo Holdings. Ms. Zier earned her MBA and Masters of Engineering from the Massachusetts Institute of Technology. Ms. Zier was appointed to each of the Audit, Compensation and Talent Management and Nominating and Governance Committees.

What is the salary of Dawn Zier?

As the Independent Director of Prestige Consumer Healthcare Inc, the total compensation of Dawn Zier at Prestige Consumer Healthcare Inc is $36,261. There are 16 executives at Prestige Consumer Healthcare Inc getting paid more, with Ronald Lombardi having the highest compensation of $5,051,680.

How old is Dawn Zier?

Dawn Zier is 55, she's been the Independent Director of Prestige Consumer Healthcare Inc since 2020. There are 11 older and 3 younger executives at Prestige Consumer Healthcare Inc. The oldest executive at Prestige Consumer Healthcare Inc is James Jenness, 73, who is the Independent Director.

Insiders trading at Prestige Consumer Healthcare Inc

Over the last 20 years, insiders at Prestige Consumer Healthcare Inc have traded over $32,224,266 worth of Prestige Consumer Healthcare Inc stock and bought 60,410 units worth $1,162,754 . The most active insiders traders include Matthew Mannelly, James M Jenness y Dawn M. Zier. On average, Prestige Consumer Healthcare Inc executives and independent directors trade stock every 62 days with the average trade being worth of $2,469,571. The most recent stock trade was executed by Mary Beth Fritz on 1 March 2024, trading 172 units of PBH stock currently worth $6,908.

What does Prestige Consumer Healthcare Inc do?

at prestige brands, now prestige consumer healthcare, we focus on product innovation and quality in over-the-counter healthcare products to improve the lives of our customers worldwide. you may not know who prestige consumer healthcare is, but you know and use our products: clear eyes, dentek, summer's eve, monistat, bc, goody's, dramamine, and many more. for generations, our trusted brands have helped consumers care for themselves and their loved ones. our mission is to preserve this trust by continuing to provide products stewarded with our customer needs in mind. prestige consumer healthcare is a different kind of company. we are the largest independent provider of over-the-counter healthcare products in north america yet we are nimble enough to give detailed attention to each and every one of our product offerings. we are constantly improving, creating products that match the ever-changing lifestyles and needs of people and families everywhere. prestige’s success as a company is th

Complete history of Ms. Zier stock trades at Spirit Airlines, Hain Celestial Inc, Tivity Health Inc, Prestige Consumer Healthcare Inc, Purple Innovation Inc y Spirit Airlines Inc

Prestige Consumer Healthcare Inc executives and stock owners

Prestige Consumer Healthcare Inc executives and other stock owners filed with the SEC include:

• Ronald Lombardi,
  Chairman of the Board, President, Chief Executive Officer
• Ronald M. Lombardi,
  Chairman, Pres & CEO
• Christine Sacco,
  Chief Financial Officer
• William PPool,
  Senior Vice President, General Counsel and Corporate Secretary
• Adel Mekhail,
  Executive Vice President - Sales and Marketing
• Christine Sacco,
  Chief Financial Officer
• Jeffrey Zerillo,
  Senior Vice President, Operations
• Adel Mekhail,
  Exec. VP of Marketing & Sales
• William C. P'Pool,
  Sr. VP, Gen. Counsel & Corp. Sec.
• Jeffrey Zerillo,
  Sr. VP of Operations
• Gary Costley,
  Lead Independent Director
• John Byom,
  Independent Director
• James Jenness,
  Independent Director
• Natale Ricciardi,
  Independent Director
• Sheila Hopkins,
  Independent Director
• Christopher Coughlin,
  Independent Director
• Dawn Zier,
  Independent Director
• Mary Beth Fritz,
  Sr. VP of Quality & Regulatory Affairs
• Dean Siegal,
  Director of Communications
• Philip David Terpolilli,
  Director of Investor Relations
• John F. Kelly,
  Director
• Lieven Nuyttens,
  Senior VP, Operations
• Partners Viii L Pgtcr Golde...,
  
• Paul Migaki,
  VP Strategic Planning/Canada
• Thomas Hochuli,
  Vice President, Operations
• David S Marberger,
  Chief Financial Officer
• Timothy Connors,
  Chief Marketing Officer
• John Parkinson,
  Senior VP- International
• Christopher Heye,
  See remarks
• Carl J Johnson,
  Director
• Samuel C Cowley,
  General Counsel, VP Bus. Dev.
• James E Kelly,
  Senior VP - Marketing
• Mark Pettie,
  Chairman of the Board and CEO
• Ronald B Gordon,
  Director
• Charles Schrank,
  Senior V.P. of Marketing
• Peter Anderson,
  Chief Financial Officer
• David Talbert,
  Senior Vice President, Sales
• Gerard Butler,
  Chief Sales Officer
• Co Invest Ii Lpgtcr Golder ...,
  
• Fund Viii Lpgtcr Partners V...,
  
• Jean A Boyko,
  SVP, Quality & Reg. Affairs
• John Byom,
  Director
• Eric S. Klee,
  Secretary and General Counsel
• Peter Mann,
  Chief Executive Officer
• L Dick Buell,
  Director
• Mezzanine Partners Lpgtcr P...,
  
• Frank Palantoni,
  President and COO
• Eric Millar,
  Senior V.P. of Operations
• Charles Hinkaty,
  Director
• Matthew Mannelly,
  President and CEO
• Michael Fink,
  Senior V.P. of Marketing
• Raymond Silcock,
  Director
• Paul A. Hennessey,
  Vice President, Operations
• Patrick Lonergan,
  Director
• Vincent J Hemmer,
  Director
• Mezzanine Partners Lpgtcr G...,
  
• Fund Viii/B L Pgtcr Partner...,
  
• Golder Rauner Ii Llc Gtcr,
  10% owner
• Capital Partners L Pgtcr Me...,
  
• David Donnini,
  Director
• Charles Jolly,
  Secretary & General Counsel
• Celeste A. Clark,
  Director
• James D Arecca,
  Director
• William P'pool,
  See Remarks
• Mary Beth Fritz,
  SVP Quality & Regulatory